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The small GTPase Arf1p is involved in different cellular processes that require its accumulation at specific cellular
locations. The recruitment of Arf1p to distinct points of action might be achieved by association of Arf1p with different
proteins. To identify new interactors of Arf1p, we performed an affinity chromatography with GTP- or GDP-bound Arf1p
proteins. A new interactor of Arf1p-GTP was identified as Pab1p, which binds to the polyA-tail of mRNAs. Pab1p was
found to associate with purified COPI-coated vesicles generated from Golgi membranes in vitro. The stability of the
Pab1p–Arf1p complex depends on the presence of mRNA. Both symmetrically distributed mRNAs as well as the
asymmetrically localized ASH1 mRNA are found in association with Arf1p. Remarkably, Arf1p and Pab1p are both
required to restrict ASH1 mRNA to the bud tip. Arf1p and coatomer play an unexpected role in localizing mRNA
independent and downstream of the SHE machinery. Hereby acts the SHE machinery in long-range mRNA transport,
whereas COPI vesicles could act as short-range and localization vehicles. The endoplasmic reticulum (ER)–Golgi shuttle
might be involved in concentrating mRNA at the ER.
INTRODUCTION
Proteins destined for secretion are packaged into coated
vesicles and transported through different cellular compart-
ments. One major factor involved in this process is the small
GTPase Arf1p. The protein is required for the formation of
COPI-coated and subclasses of clathrin-coated vesicles
(Kirchhausen, 2000). In addition, there is growing evidence
that Arf1p plays a role in rearrangements of the cytoskeleton
as well as in lipid metabolism (Fucini et al., 2000; Skippen et
al., 2002). In higher eukaryotes, different members of the
class I family of ARF proteins may play these distinct roles.
However, in the yeast Saccharomyces cerevisiae only three
ARF proteins have been identified. Arf1p and Arf2p are 96%
identical, but Arf1p is 10 times more abundant than Arf2p
(Stearns et al., 1990). Arf3p seems to fulfill similar functions
to mammalian ARF6, a class III ARF, and plays a role in
endocytosis (Lee et al., 1994; Givan and Sprague, 1997).
Given the diverse requirements for Arf1p, its function needs
to be tightly regulated in a temporally and spatially corre-
lated manner and must therefore pivot on effector molecules
that determine the specificity of the different Arf1p-depen-
dent events. The guanine nucleotide-bound state of Arf1p is
controlled by a guanine nucleotide exchange factor (ARF-
GEF) and a GTPase-activating protein (ARF-GAP). In yeast,
three ARF-GEFs with established functions have been iden-
tified: Gea1p, Gea2p, and Sec7p. Gea1p and Gea2p have
overlapping functions in retrograde transport from the
Golgi to the endoplasmic reticulum (ER), whereas Sec7p has
been implicated in vesicle formation from the trans-Golgi
(Franzusoff et al., 1992; Spang et al., 2001). The cellular role of
the fourth Sec7-domain containing protein, Syt1p, is still
unclear, but it might act at the post-Golgi level (Jones et al.,
1999). Which of the GEFs mediates the other Arf1p-depen-
dent transport steps remains to be established. ARF-GAPs
outnumber the ARF-GEFs in the cell. At least six putative
ARF-GAPs are present in the yeast genome. Gcs1p and
Glo3p have overlapping functions in retrograde transport
from the Golgi to the ER (Poon et al., 1999). Yet, only Glo3p
interacts directly with coatomer (Lewis et al., 2004). Age2p
can be replaced by Gcs1p in the endocytic pathway (Poon et
al., 2001). In addition, Gcs1p influences actin polymerization
dynamics in yeast (Blader et al., 1999). The reuse of the same
molecules for different tasks implies that these known reg-
ulators of Arf1p GTPase activity might be insufficient to
target Arf1p to the different cellular locations required to
perform its multiple functions. Furthermore, additional re-
quirements for Arf1p in the cell might exist that are still
veiled.
To identify additional interactors and effectors of Arf1p,
we took a differential affinity chromatography approach
with mutants restricted to the either GTP- or GDP-bound
form of Arf1p. Unexpectedly, we found that Pab1p specifi-
cally interacts with the activated form of Arf1p (Arf1p-GTP),
and formation of the Pab1p–Arf1p complex requires the
presence of mRNA. Pab1p is the major polyA-binding pro-
tein in yeast and is required for translation and mRNA
stability in the cell. Arf1p-Pab1p ribonucleotide particles
contain both symmetrically and asymmetrically distributed
mRNAs. These ribonucleotide particles are associated with
COPI vesicles derived from the Golgi apparatus. Impor-
tantly, our results indicate that Pab1p and Arf1p cooperate
to correctly localize ASH1 mRNA in the bud tip of growing
yeast cells. ASH1 mRNA is one of at least two mRNAs that
are asymmetrically localized to the bud of exponentially
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growing yeast cells (Long et al., 1997; Takizawa et al., 2000;
Shepard et al., 2003). The mechanism of the asymmetric
localization of the mRNA is dependent on the She proteins.
These proteins include the motor protein Myo4p (She1p) as
well as an RNA binding protein (She2p) (Bohl et al., 2000;
Long et al., 2000; Takizawa and Vale, 2000). No role in
mRNA localization for proteins involved in vesicular traffic
had been evident. However, we now show that components
of the early secretory transport machinery are required for
keeping the asymmetrically distributed mRNA in the bud
tip and additionally might bring symmetrically distributed
mRNA to the ER. This process is independent of the SHE
machinery.
MATERIALS AND METHODS
Yeast Methods and Protein Expression
Escherichia coli BL21(DE3)pLysS (Novagen, Madison, WI) was used for pro-
tein expression. Yeast strains used in this study are listed in Table 1. Standard
genetic techniques were used throughout (Sherman, 1991). Chromosomal
tagging and deletions were performed as described in Knop et al. (1999).
Arf1p Affinity Chromatography
Recombinant N17-Arf1Q71Lp and N17-Arf1T31Np were expressed in E.
coli and purified as described by Rein et al. (2002). Fifty milligrams of each
protein was covalently coupled to 1.2 ml of N-hydroxysuccinimide (NHS)-
activated Sepharose 4 fast flow (Amersham Biosciences, Freiburg, Germany).
Yeast cytosol was prepared as described in Spang and Schekman (1998).
For the affinity chromatography, the columns were preequilibrated with 10
ml of NE buffer (25 mM HEPES, pH 7.7, 100 mM NaCl, 1 mM EDTA, 0.5 mM
MgCl2, 0.1% Na-cholate). The nucleotide exchange was performed in 3 ml of
NE buffer with 200 M of the corresponding nucleotide for 1 h at 37°C (GTP
for Arf1Q71Lp, GDP for Arf1T31Np). The control column without protein
was treated in the same way as the Arf1Q71Lp-column. The columns were
washed with 10 ml of NS buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM
dithiothreitol, 1 mM EDTA, 2 mM MgCl2, 10 M GXP). Yeast cytosol (125 mg)
was allowed to bind for 1 h at 4°C. The columns were washed with 60 ml of
NS buffer ( 0.1% Triton X-100) and subsequently with 10 ml of prewarmed
exchange buffer containing 10 M GXP. Proteins were eluted using 4 1 ml
exchange buffer containing 500 M GXP (GDP for Arf1Q71Lp, GTP for
Arf1T31Np). For the first elution, the columns were incubated for 30 min at
37°C, whereas for the following elution steps 10 min was used. The samples
were analyzed by immunoblot. The mass spectrometric analysis was per-
formed as described by Sandmann et al. (2003).
Two-Hybrid Assay
The two-hybrid assay was performed with the LexA two-hybrid system
(Golemis and Khazak, 1997). The yeast reporter strain EGY48 with the bait
plasmid pEG202, the prey plasmid pJG4-5, and the reporter plasmid
pSH18-34 were used. PAB1 and PUB1 were amplified from genomic yeast
DNA by polymerase chain reaction (PCR) and cloned into pJG4–5. Constructs
were verified by DNA sequencing.
Coimmunoprecipitation Experiments and Reverse
Transcription-Polymerase Chain Reaction (RT-PCR)
Yeast lysates were prepared by spheroplasting as described by Spang and
Schekman (1998). Spheroplasts were sedimented and lysed in 20 mM HEPES,
TABLE 1. Yeast strains used in this study
Strain Genotype Source
GPY60 MAT ura3-52 leu2,3-112 his4-579 pep4::ura3 prb1 trp4-579 R. Schekman
YPH500 MAT ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 P. Hieter
W303-1Aa MATa ade2-1 ura3-1 trp1-1 his3-11,15 leu2,3-112 can1-100 P. Poon
YAS321 MAT ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 arf1::HIS3MX6 This study
YAS147 MAT ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 pG14-MS2-GFP (LEU2)
YEP15-Lz-MS2-ASH1–3UTR (URA3)
This study
YAS324 MAT ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 arf1::HIS3MX6 pG14-MS2-GFP (LEU2)
YEP15-Lz-MS2-ASH1–3UTR (URA3)
This study
YAS212 MAT ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 ARF1::ARF1-6HA-klTRP1 This study
YAS225 MATa ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 PAB1::PAB1-9myc-klTRP1 This study
YAS238 ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 ARF1::ARF1–6HA-klTRP1 PAB1::PAB1-9myc-klTRP1 This study
YAS258-A ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 ARF1::ARF1-YFP-HIS3MX6 This study
YAS258-B ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 ARF1::ARF1-YFP-HIS3MX6 PAB1::PAB1-CFP-KANMX6 This study
YAS258-C ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 PAB1::PAB1-CFP-KANMX6 This study
YAS258-D ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 This study
YAS259-A ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 ARF1::ARF1-CFP-KANMX6 PAB1::PAB1-YFP-HIS3MX6 This study
YAS259-B ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 ARF1::ARF1-CFP-KANMX6 This study
YAS259-C ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 This study
YAS259-D ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 PAB1::PAB1-YFP-HIS3MX6 This study
NYY0-1 MATa ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 A. Nakano
NYY11-1 MATa ade2::arf1-11::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 A. Nakano
NYY17-1 MATa ade2::arf1-17::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 A. Nakano
NYY18-1 MATa ade2::arf1-18::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 A. Nakano
RSY248 MAT his4-619 R. Schekman
RSY271 MAT his4-619 sec18-1 R. Schekman
RSY1017 MAT his3-200 ura3-52 pep4::URA3 sec21-1 R. Schekman
RSY281 MAT his4-619 ura3-52 sec23-1 R. Schekman
RSY1312 MATa leu2,3-112 trp1 ura3-52 sec27-1 R. Schekman
sar1-D32G MAT ura3 leu2 trp1 his3 ade2 lys2 sar1::HIS3 pep4::ADE2 pMYY3-1(YCpsar1-D32G TRP1) A. Nakano
RJY585 MATa ade2-1 his3-11 leu2-3 trp1-1 ura3 HO-ADE2 HO-CAN1 ASH1::HIS3 (S. pombe) R. Jansen
YAS2314 MATa ade2 his3 leu2 trp1 ura3 spb8::LEU2 pab1::HIS3 A. Sachs
BY4741 MATa his31 leu20 met150 ura30 EUROSCARF
arf1 MATa his31 leu20 met150 ura30 arf1::KanMX4 EUROSCARF
arf2 MATa his31 leu20 met150 ura30 arf2::KanMX4 EUROSCARF
bfr1 MATa his31 leu20 met150 ura30 bfr1::KanMX4 EUROSCARF
YAS318-D his31 leu20 MET15 lys20 ura30 arf1::HIS3MX6 bfr1::KanMX4 This study
scp160 MATa his31 leu20 met150 ura30 scp160::KanMX4 EUROSCARF
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pH 6.8, 150 mM KAc, 5 mM Mg(Ac)2, 1% Tween 20. The lysates were cleared
by centrifugation. Immunoprecitpitations were performed with 10 l of
-Arf1p serum, 10 l of -COPI, or control serum per 1 ml of lysate for 1 h at
4°C. In other cases, 7 l of -HA.11 (Babco, Richmond, CA) or 5 l of -myc
9E10 (Sigma-Aldrich, St. Louis, MO) were added to the lysate.
For Bfr1p coimmunoprecipitation, the lysate was incubated with 10 l of
affinity-purified anti-Arf1p antibody cross-linked to 25 l of protein A mag-
netic beads (New England Biolabs, Beverly, MA) by using dimethyl pime-
limidate (Pierce Chemical, Rockford, IL). The antibody–protein interaction
was severed by elution with 0.2 M glycine, pH 2.5.
For RNA digestion experiments, the lysates were treated for 35 min at 4°C
with 200 g of RNase A (Roche Diagnostics, Indianapolis, IN) or 500 U of
RNase-free DNase I and centrifuged before precipitation.
For RT-PCR, the beads and the lysates were extracted as described by
Gonsalvez et al. (2003). RT-PCR was performed using One-Step RT-PCR kit
(QIAGEN, Hilden, Germany) for 25 or 30 cycles.
ASH1 mRNA Localization
For the visualization of ASH1 mRNA localization by green fluorescent protein
(GFP) particles, the reporter system by Bertrand et al. (1998) was used.
In situ ASH1 mRNA hybridization with digoxigenin-labeled ASH1 anti-
sense probe was performed as described previously (Takizawa et al., 1997).
Where necessary, cells were shifted for 1 h to the nonpermissive temperature.
At least 100 cells were counted for each condition, and a minimum of three
independent experiments were performed per strain.
Northern Blot Analysis
Cells were grown overnight to logarithmic phase. When necessary, cells were
shifted for 1 h to the nonpermissive temperature. Total RNA was extracted
using the RNeasy kit (QIAGEN), and equal amounts of RNA were resolved
on agarose gels containing formaldehyde. The RNA was transferred onto
Hybond N (Amersham Biosciences) and subsequently hybridized to ASH1
and ADH1 probes, which were generated using an AlkPhos direct labeling kit
(Amersham Biosciences). The probes were detected using the CDP-Star re-
agent (Amersham Biosciences) according to manufacturer’s recommenda-
tions.
Golgi Budding Assay
The Golgi membranes were prepared and the Golgi budding assay was
performed as described by Spang and Schekman (1998) with the following
modifications. For the Golgi budding reactions, membranes were incubated
with 0.1 mM GTP or guanosine 5-O-(3-thio)triphosphate (GTP--S), coatomer
(125 g/ml), and Arf1p (25 g/ml) at 30°C for 30 min in a total volume of 400
l. After chilling on ice, we loaded the samples on a Ficoll-sucrose gradient
consisting of 0.3 ml of 60% (wt/vol) sucrose, 0.8 ml of 7.5%, 1 ml of 5, 4, and
3%, and 0.8 ml of 2% (wt/wt) Ficoll in 15% (wt/vol) sucrose in 20 mM HEPES,
pH 6.8, 5 mM MgAc2, 150 mM KAc (B88*). The vesicles were separated from
the Golgi apparatus by centrifugation for 2 h at 35,000 rpm (SW50.1 rotor;
Beckman Instruments, Fullerton, CA). Fractions (400 l) were collected from
the top. Fractions 4–6 of the gradients were pooled, mixed with an equal
volume of 80% Nycodenz in B88*, and overlaid with 600 l of 35, 25, 20, and
15% and 400 l of 10% Nycodenz in B88*. The gradients were centrifuged for
16 h at 40,000 rpm (SW50.1 rotor; Beckman Instruments). Fractions (300 l)
were collected from the top, trichloroacetic acid (TCA) precipitated, and
analyzed by immunoblot.
RESULTS
Identification of Interactors of Arf1p
To identify new interacting proteins for Arf1p, we performed
affinity chromatography with dominant active (N17-
Arf1Q71Lp) and dominant inactive (N17-Arf1T31Np) forms
of Arf1p (Kahn et al., 1995). We chose an N-terminal truncated
form of Arf1p for our experiments because the N terminus
contains a myristoylation site and forms an amphipathic helix.
The replacement of this region of the proteins by a His6-tag
should minimize nonspecific interactions on the affinity col-
umn, and it greatly facilitated the purification (Rein et al., 2002).
Equal amounts of N17-Arf1Q71Lp and N17-Arf1T31Np
were covalently coupled to NHS-agarose. Guanine nucleotide
exchange reactions were performed on the immobilized pro-
teins to ensure that Arf1Q71Lp and Arf1T31Np were bound to
GTP and GDP, respectively. Cytosolic extracts from a wild-
type yeast strain were passed over the columns. For the elution,
the Arf1Q71Lp column was incubated with an excess of GDP
and the Arf1T31Np column with an excess of GTP. Although
the restricted mutants are predominantly in either the GTP- or
the GDP-bound form, an excess of the other nucleotide was
able to elicit a conformational change under conditions that
favor spontaneous guanine nucleotide exchange. In this way,
proteins were released that bound specifically to the active or
inactive form of Arf1p (Figure 1A). An NHS-agarose column,
which had been mock treated, served as a negative control.
We validated our approach with immunoblots of eluates
from the different columns and antibodies directed against
known interactors of Arf1p, e.g., coatomer, ARF-GEFs, and
the ARF-GAP Glo3p. These proteins behaved as predicted
by their biological function (our unpublished data).
Coatomer is heptameric protein complex that forms together
with Arf1p the COPI coat. This coat is involved in vesicular
transport within the Golgi and from the Golgi to the ER.
Eluted proteins were precipitated with trichloracetic acid
and then separated by SDS-PAGE and stained with Coomas-
sie Blue (Figure 1B). Multiple proteins were eluted from both
Arf1p columns. Whereas some proteins occurred in eluates
from both Arf1p columns, a few proteins were at least
predominantly present in fractions from only one of the
columns. Bands present in the eluates from only one column
were excised and analyzed by mass spectrometry. The re-
sults of the analysis are summarized in Table 2. Six of the
analyzed bands corresponded to known Arf1p binding pro-
teins: subunits of the coatomer complex, the ARF-GEFs
Gea2p and Sec7p as well as the ARF-GAP Gcs1p. Similar
results were obtained using columns with immobilized
N17-Arf1p bound to GTP or GDP. Surprisingly, Gcs1p was
found in the eluate from the GDP column. However, ARF-
GAPs have been shown to fulfill an additional function on
recruitment of SNAREs and cargo to sites of vesicle emer-
gence (Rein et al., 2002). This recruitment does not necessar-
ily require the activated state of Arf1p.
Pab1p Binds to a N17-Arf1Q71Lp Affinity Matrix
One of the new bands that we identified by mass spectrom-
etry corresponded to Pab1p (Figures 1B, band 6, and Table
2). Pab1p is one of two major polyA-tail binding proteins in
yeast. It is localized in the cytoplasm as well as in the
nucleus, and it is part of the 3 end RNA processing complex
(cleavage factor I). Four RNA recognition domains mediate
the interaction with the polyA-tail of the mRNA. To confirm
the presence of Pab1p, we tested eluates from the affinity
columns by immunoblot. Pab1p did not bind to the column
material, but it was detected in fractions from the N17-
Arf1Q71Lp column (Figure 1C). A small amount of Pab1p
also was present in eluates from the N17-Arf1T31Np col-
umn. However, Pab1p showed a higher affinity toward the
activated form of Arf1p, because the signal from the
Arf1T31Np fractions trailed off quickly, whereas it persisted
throughout the eluates from the Arf1Q71Lp matrix. This
was consistent with the signal that we observed for
coatomer. If the Pab1p–Arf1Q71Lp interaction represents a
high-affinity contact, one would expect that the cytosol
loaded on the column would be at least partially depleted of
Pab1p. Therefore, the flow-throughs from different columns
were analyzed by immunoblot. Although the signal from the
control and the N17-Arf1T31Np columns did not alter
significantly, the cytosol that had passed through the N17-
Arf1Q71Lp matrix contained substantially less Pab1p than
the starting material (Figure 1D).
N17-Arf1Q71Lp Interacts with Pab1p but Not Pub1p
Pab1p is known to bind nonspecifically to many yeast pro-
teins (Gavin et al., 2002). Therefore, to validate the interac-
tion between Arf1p and Pab1p, we performed a two-hybrid
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assay. We used N17-ARF1Q71L as the bait and PAB1, PUB1,
and GLO3 as prey. Pub1p is the other major polyA binding
protein in the cell, and like Pab1p, it localizes to the cytoplasm
and the nucleus. We used growth on –LEU plates as the indi-
cator for interactions. Whereas PAB1 and N17-ARF1Q71L
showed an interaction in the two-hybrid assay, no growth on
–LEU plates could be detected in strains carrying PUB1 in
conjunction with N17-ARF1Q71L. GLO3 served as a positive
and the empty vector as a negative control, respectively (Table
3). Eugster et al. (2000) have shown that GLO3 specifically
interacts with the active form of N17-ARF1 but neither with
the wild-type nor the inactive mutant.
Figure 1. Differential affinity chromatography. Yeast cytosol was incubated with either the Arf1-Q71Lp (Arf1p-GTP) or Arf1-T31Np
(Arf1p-GDP) column. After washing, spontaneous nucleotide exchange was elicited resulting in a conformational change on Arf1p and the
release of conformation-specific bound proteins. (A) Schematic drawing of the procedure. (B) The eluates from a differential affinity
chromatography experiment were TCA precipitated and separated on an SDS gel. Bands that were enriched in eluates from either the
Arf1p-GDP or Arf1p-GTP column were excised and subjected to mass spectrometric analysis. (C) Pab1p binds preferentially to N17Arf1-
Q71Lp. Fractions from the columns were blotted and incubated with antibodies against Pab1p. Pab1p is highly enriched in eluates from the
Arf1p-Q71L column. (D) The flow-through from the Arf1-Q71Lp column is depleted of Pab1p. The starting cytosol as well as the
flow-through from the three columns was analyzed for the presence of Pab1p by immunoblot. Pab1p was less abundant in the flow-through
of the Arf1p-GTP column compared with the mock-treated and the Arf1p-GDP column.
M. Trautwein et al.
Molecular Biology of the Cell5024
Pab1p is essential for cell viability. However, a suppressor
mutant has been identified, spb8, that allows for survival in
the absence of functional Pab1p (Boeck et al., 1998). ARF1 is
not essential because its homolog ARF2, which is 96% iden-
tical, can at least partially substitute for ARF1. Yet Arf1p and
Arf2p are not fully redundant (Spang et al., 2001). If Arf1p
and Pab1p cooperate in an essential pathway, one would
predict that a double mutant should show at least an en-
hanced phenotype compared with the single mutants. Thus,
we crossed a arf1 strain with a pab1 spb8 strain (Figure
2). Although the pab1 spb8 mutant had a somewhat re-
duced growth rate compared with wild type, the arf1 pab1
spb8 spores were very sick and hardly grew at any tem-
perature. In contrast, arf2 did not show the same pheno-
type with pab1spb8, most likely because Arf2p is much
less abundant in the cell than Arf1p and Arf1p is still present
in arf2 strains. In addition, we constructed a strain contain-
ing chromosomally tagged Arf1p-YFP and Pab1p-CFP,
which was cold sensitive (Figure 2). The singly tagged
strains do not show this phenotype. Therefore, the cold
sensitivity provides additional evidence for the specific in-
teraction between Arf1p and Pab1p in vivo. Together, these
results are consistent with an interaction of Arf1p and Pab1p
in vivo.
Pab1p and Arf1p Form a Complex In Vivo
As a further test of binding specificity, we performed coim-
munoprecipitation experiments. First, we appended chro-
mosomally Arf1p and Pab1p with a hemagglutinin (HA)-tag
and a myc-tag, respectively. The resulting strain, YAS238,
did not show an altered phenotype compared with the iso-
genic wild-type (our unpublished data). Lysates of strain
YAS238 were incubated with anti-HA or anti-myc antibod-
ies and protein G-Sepharose. The immunoprecipitates were
resolved by SDS-PAGE followed by immunoblot with anti-
bodies against coatomer, and the HA- and the myc-tag
(Figure 3, A and B). As expected, Pab1p-myc was coprecipi-
tated with Arf1p-HA. This precipitation was dependent on
the presence of Arf1p-HA. A similar result was obtained
when the Pab1p-myc was precipitated: Arf1p-HA cosedi-
mented only in the presence of Pab1p-myc (Figure 3B).
Unexpectedly, coatomer also was precipitated with Pab1p-
myc. Because coatomer also seemed to be part of an Arf1p–
Pab1p complex, we repeated the immunoprecipitation with
wild-type lysate and anti-coatomer antibodies. Indeed,
Pab1p was found in the immunoprecipitate but not in the
control (Figure 3D; our unpublished data). Moreover, Pab1p
failed to coimmunoprecipitate when antibodies against
Sar1p or Sec23p were used. Sec23p is the GTPase activating
protein of Sar1p, and both are essential for the formation of
COPII-coated vesicles from the ER. Thus, Pab1p does not
associate nonspecifically with vesicle coat proteins. To-
gether, these results provide further evidence for the exis-
tence of an in vivo Pab1p-Arf1p interaction and that
coatomer is part of this complex.
Pab1p Is Associated with Golgi-derived COPI Vesicles
The results presented thus far support an in vivo interaction
of coatomer, Arf1p, and Pab1p. Such an interaction could
take place on the Golgi or on COPI vesicles. Pab1p is evenly
distributed throughout the cytoplasm (Anderson et al.,
1993), making it difficult to assess the place of interaction in
vivo. Therefore, we used an in vitro Golgi budding assay, in
which COPI-coated vesicles are formed from Golgi mem-
branes (Spang and Schekman, 1998). Enriched Golgi mem-
branes that were devoid of ER were incubated in the pres-
ence of coatomer, Arf1p, and guanine nucleotide. The
generated COPI vesicles were separated from the Golgi
membranes by velocity centrifugation. The vesicle peak was
collected and refractionated based on coated membrane
buoyant density. By using this purification scheme, vesicles
are highly enriched, because contaminating particles would
have to show the same behavior on a sedimentation gradient
as well as sharing the same buoyant density, which is very
unlikely. When GTP--S was used to generate the COPI-
coated vesicles, the vesicles peaked in fractions 5 and 6 as
judged by the presence of the integral membrane cargo
Emp47p and the v-SNARE Bos1p (Figure 4, GTP--S). Pab1p
peaked in the same fractions. A strong signal of Pab1p also
was observed in the load. This was not surprising because
we expected Pab1p to travel piggyback on the COPI vesicles.
Thus, some protein if not most was lost during the flotation
process. We did not detect any Sec61p, the translocon at the
ER, or Pgk1p, a very abundant cytosolic protein in the
vesicle fraction (our unpublished data). The peak changed in
appearance when GTP was used instead of GTP--S. In this
case, the coat partially disassembled due to GTP hydrolysis,
which also resulted in a partial loss of the Pab1p signal in the
vesicle fraction. Pab1p was not recovered in the vesicle peak
in the absence of coatomer and Arf1p (our unpublished
data). Thus, Pab1p is associated with COPI vesicles gener-
ated from Golgi membranes, and this association is lost after
the disassembly of the COPI coat.
The Pab1p–Arf1p Complex Is Dependent on the Presence
of mRNA
Pab1p is the major mRNA binding protein of the cell. There-
fore, we wanted to test whether RNA is present in the
Pab1p–Arf1p complex and whether RNA is required for the
stability of the complex. To address these questions, we
performed an immunoprecipitation with anti-Arf1p anti-
bodies and digested the lysate with either RNase A or
DNase I (Figure 3C). Pab1p was coimmunoprecipitated with
anti-Arf1p antibodies, and it did not bind to nonrelated IgGs
(Figure 3C). Interestingly, the interaction of Arf1p and
Pab1p was severed upon addition of RNase A. DNA diges-
TABLE 2. Proteins identified by mass spectrometry
Band Protein Description
1 Cop1p Coatomer -subunit
3 Sec26p Coatomer -subunit






TABLE 3. Two-hybrid assay
Bait
Prey
PAB1 PUB1 GLO3 pJG4-5
N17-ARF1-Q71L    
pEG202  n.d.  n.d.
n.d., not done.
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tion did not have any influence on the stability of the Pab1p–
Arf1p complex. Furthermore, the addition of an excess of
purified RNA or DNA did not have any impact on the
Pab1p–Arf1p interaction, indicating that binding is not me-
diated by a nonspecific association of protein and RNA.
Thus, Arf1p seems to be part of a ribonucleotide particle.
Next, we wondered whether Arf1p might be part of special
3 end RNA processing complexes. Therefore, we performed
RT-PCRs on anti-Arf1p immunoprecipitates (Figure 3D). We
tested eight mRNAs that differ in their abundance and that
are either symmetrically or asymmetrically localized. In S.
cerevisiae, at least two asymmetrically localized mRNAs have
been identified: ASH1 and IST2. They are transported into
the bud along actin cables via the SHE machinery and an-
chored at the bud tip of a growing cell (Long et al., 1997;
Munchow et al., 1999; Takizawa et al., 2000). The motor
protein Myo4p forms a complex with the RNA binding
protein She2p via She3p (Bohl et al., 2000; Long et al., 2000;
Takizawa and Vale, 2000). This complex delivers the mRNA
to the bud tip where it is anchored.
As shown before, Pab1p specifically precipitated with af-
finity-purified anti-Arf1p antibodies and not with control
IgGs (Figure 3D). Using this precipitate as template for the
RT-PCR for different mRNAs resulted in a positive signal for
all tested mRNAs. These signals were specific because no
product was detected in the lanes where a precipitate with
Figure 2. ARF1 but not ARF2 interacts genetically with PAB1. (A) arf1 or arf2 haploid strains were crossed with pab1spb8 strains. The
resulting diploid strains were sporulated and tetrads dissected. The spores were grown for 2 d at 30°C. (B) ARF1 and PAB1 were
chromosomally appended with either yellow fluorescent protein (YFP) or cyan fluorescent protein (CFP). The resulting strains were grown
to early log phase, and serial dilutions were spotted on YPD plates. The plates were incubated at the indicated temperatures.
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Figure 3. Arf1p and Pab1p are present in a ribonucleotide particle. (A and B) Pab1p and Arf1p coimmunoprecipitate. Pab1p and Arf1p were
chromosomally appended with either a myc- or HA-tag. Yeast lysates were prepared from single- or double-tagged strains and subjected to
immunoprecipitation with anti-myc or anti-HA antibodies. The precipitates were analyzed by immunoblot. Lanes 1 and 2 correspond to 1.7%
of the lysate. (C) Pab1p–Arf1p interaction depends on mRNA. Yeast lysate from a wild-type strain was incubated with RNase A, DNase I,
or mock treated. After the treatment an immunoprecipitation was performed with anti-Arf1p serum or a control serum and protein
A-Sepharose. The precipitated proteins were detected by immunoblot. In lane 1, 1.7% of the lysate was loaded. (D) ASH1 mRNA is part of
the Pab1p-Arf1p ribonucleotide particle even in the absence of the SHE machinery. A coimmunoprecipitation experiment was performed
with affinity-purified anti-Arf1p antibodies. RNA was prepared from the precipitate and subjected to RT-PCR with primer specific for the
indicated mRNAs. RT indicates reactions in the absence of reverse transcriptase. In lanes 1 and 2, 1.7% of the lysate was loaded.
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control IgGs had been used at 25 cycles. Increasing the cycle
number to 30 resulted in a signal also in the control for most
of the mRNAs except for ASH1. This result indicates that the
Arf1p-Pab1p particles contain a variety of different mRNAs.
Because we also detected the asymmetrically localized
ASH1 and IST2 mRNAs in Arf1p-Pab1p ribonucleotide par-
ticles, we asked whether interfering with the SHE machinery
also would affect the association of the asymmetrically lo-
calized ASH1 mRNA with the COPI vesicles. Therefore, we
repeated the Arf1p immunoprecipitation in strains where
either SHE1/MYO4 or SHE3 had been deleted. As observed
in the wild type, Pab1p cosedimented with Arf1p (Figure
3D, compare lane 4 with lanes 6 and 7). Furthermore, the
precipitated mRNA contained ASH1 mRNA. Therefore, the
association of the asymmetrically localized mRNA ASH1
with the Arf1p–Pab1p complex is independent of its trans-
port by the SHE machinery.
We have established that Pab1p is present on COPI vesi-
cles. Furthermore, ASH1 mRNA was detected on the COPI
vesicle fraction of a Golgi budding experiment (our unpub-
lished data). Yet, does this interaction of Pab1p and Arf1p
depend on the presence of mRNA? To address this question,
we again performed a Golgi budding experiment (Figure 4).
This time, however, we added RNase during COPI vesicle
generation. Treatment of the Golgi membranes with RNase
did not affect vesicle generation, but the association of Pab1p
with the COPI vesicles was completely lost. Therefore, the
attachment of Pab1p with Golgi-derived COPI vesicles re-
quires the presence of mRNA.
Asymmetric mRNA Localization Is Disturbed in arf1
Mutants
The Arf1p-Pab1p ribonucleotide particles contain asym-
metrically and symmetrically localized mRNA. Thus, COPI
vesicles are likely to contain a wide repertoire of mRNAs.
These COPI vesicles are required for intra-Golgi as well as
Golgi-to-ER retrograde transport. Because COPI vesicles are
transport carrier, it seemed reasonable to look for a link to
mRNA transport. One possible role for the mRNA associa-
tion with the vesicles could be to bring the mRNA to the ER.
The ER is a reticulate structure distributed throughout the
cell, and we found it hard to study the transport of symmet-
rically localized mRNAs. Therefore, we investigated an
asymmetrically distributed mRNA, ASH1, that also was
found on COPI vesicles. First, we tested whether deletion of
ARF1 interferes with the localization of ASH1 mRNA by
using a GFP-based mRNA-localization assay (Bertrand et al.,
1998). GFP is fused to sequences encoding the viral MS2 coat
protein, whereas an ASH1 mRNA reporter construct con-
tains MS2 binding sites. A nuclear localization signal on the
GFP-containing plasmid restricts GFP to the nucleus. Only
after interaction of the MS2 coat protein with MS2 binding
sites can GFP exit the nucleus with ASH1 mRNA. We com-
pared the ASH1 mRNA localization of wild-type yeast cells
to that in a arf1 strain (Figure 5). We scored three different
phenotypes: bud tip (correct localization), bud neck, and
mother cell. In the wild-type strain, 	60% of cells showed
the correct localization of ASH1 mRNA in the bud tip at 30
and 16°C. In contrast, ASH1 mRNA seemed to be mislocal-
ized in arf1 cells at the permissive temperature and even
more severely at the restrictive temperature. Only in 20%
of the arf1 cells incubated at the restrictive temperature
was the GFP signal confined to the bud tip. The ASH1
mRNA never seemed to reach the bud tip in the remaining
80% of the cells. The GFP particle was either stuck in the bud
neck or was randomly localized in the mother cell. This
result indicates that Arf1p is required for the correct local-
ization of ASH1 mRNA.
We extended our results by using temperature-sensitive
arf1 alleles in a arf2 background generated by Yahara et al.
(2001). In these strains, ARF function is only provided by the
arf1 ts-allele. In addition, we switched our detection method
to fluorescence in situ hybridization (FISH). The strains were
grown overnight under permissive conditions, shifted for
1 h to the restrictive temperature, and then prepared for
FISH analysis. Strain NYY 0-1 corresponds to the “wild
type” in this experiment, because it contains the wild-type
allele of ARF1 in a arf2 background, whereas NYY11-1,
NYY17-1, and NYY18-1 represent different point mutants
(Figure 6B). NYY11-1 carries three point mutations, one of
which is in proximity to the switch 1 domain. The other two
mutations are toward the C terminus, which is probably
Figure 4. Pab1p association with COPI-coated vesicles is dependent on mRNA. COPI vesicles were generated from Golgi membranes in the
presence of GTP--S and COPI components. In one experiment, RNase (200 g) was added to the budding reaction. The vesicles were
purified over a velocity gradient and subsequently floated on a Nycodenz gradient. Fractions were collected from the top, separated by
SDS-PAGE, and analyzed by immunoblot. The arrows indicate the direction of movement of lipid particles within the gradient. Nonmem-
brane-associated proteins remain in the load at the bottom of the gradient. The vesicles peak in fractions 5 and 6.
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involved in protein–protein interaction. NYY11-1 has a
strong defect in Golgi-to-ER transport. NYY17-1 (mutated in
the switch 1 region) seems to be a weaker allele and is a
member of a different intragenic complementation group.
NYY18-1 is supposed to disturb transport at the Golgi and
carries a mutation in the switch 2 region (Figure 6B). At the
restrictive temperature, only 50% of the ARF1 wild type
showed correct localization of the ASH1 mRNA (Figure 6C).
However, the mutant NYY17-1 was not defective in mRNA
localization and showed 70% correctly anchored ASH1
mRNA. In contrast, the mRNA localization in NYY11-1 and
NYY18-1 was severely affected. The predominant defect was
delocalized mRNA throughout the cell, indicating that these
mutants were either deficient in transport or anchoring of
the mRNA in the bud tip. These results indicate that the
mRNA mislocalization phenotype displayed by the different
mutants is due to a specific involvement of Arf1p in this
process.
arf1 Mutants Show No Defects in Transcription or
Translation of ASH1
Anchoring of ASH1 mRNA depends at least in part on Ash1
protein translation (Gonzalez et al., 1999). Therefore, the
results presented above, although specific for Arf1p, also
could be interpreted as a defect in transcription, mRNA
instability, or down-regulation of translation of ASH1. In
addition, some mutants of components along the secretory
pathway led to a defect in ribosome biosynthesis (Mizuta
and Warner, 1994). Moreover, Deloche et al. (2004) reported
that translation initiation was attenuated very rapidly, and
protein synthesis was reduced in secretion mutants upon
shift to restrictive conditions. To test effects on ASH1 mRNA
stability and Ash1p protein synthesis in arf1 and pab1 mu-
tant strains before and after shift to the restrictive tempera-
ture, we performed Northern and Western blots (Figure 6, D
and E). Yet, no significant variations in ASH1 mRNA levels
were detected in arf1 ts-mutant strains upon shift to nonper-
missive conditions or in strains where ARF1 or PAB1 had
been deleted (Figure 6D). Detection of ADH1 mRNA served
as internal control. A myc-tagged version of Ash1p is func-
tional and has been used to assess the Ash1p content in cells
(Cosma et al., 1999; McBride et al., 2001). Therefore, we used
Ash1p-myc expressed from a CEN plasmid (single copy) to
determine Ash1p levels in arf1 and pab1 mutants. Soluble
yeast lysates were analyzed for the presence of Ash1p-myc
and Arf1p (Figure 6E). As observed for the mRNA levels, no
significant differences in the Ash1p levels were eminent.
Thus, it is unlikely, that transcription or translation of ASH1
is disturbed in the arf1 mutants and that this would be the
cause of the ASH1 mRNA localization defect.
Figure 5. ASH1 mRNA is mislocalized in
arf1 mutant cells. An ASH1 mRNA-GFP
reporter system was transformed in either
wild-type or the isogenic arf1 strain. Cells
were grown to early log phase at 30°C. One-
half of the cultures were shifted to 16°C for
3 h. At least 100 cells per strain and temper-
ature were analyzed for the localization of
the GFP particle. The scored phenotypes are
indicated. The arrowheads point toward the
green fluorescent particle.
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pab1sbp8, scp160, and bfr1 Are Defective in ASH1
mRNA Localization
Next, we wanted to check whether Pab1p also is required for
asymmetric mRNA localization. Cells of a pab1sbp8 strain
were grown at 30°C and prepared for FISH as described
above. Indeed, a similar phenotype was observed as for a
arf1 mutant (Figure 7A). In both cases, 60% of the ASH1
mRNA was mislocalized, whereas in the wild type 60% of
the cells the signal was observed anchored in the bud tip.
Pab1p is known to interact with two other proteins, Scp160p
and Bfr1p (Lang and Fridovich-Keil, 2000). Moreover,
Scp160p has been identified as a multicopy suppressor of a
gea1-4 gea2 mutant and physically interacts with Gea1p
(Peyroche and Jackson, 2001). Gea1p and Gea2p are ARF-
GEFs that have overlapping functions in retrograde trans-
port from the Golgi to the ER (Peyroche et al., 1996; Spang et
al., 2001). Scp160p is a polysome-associated protein that was
shown to be defective in anchoring asymmetrically localized
mRNA (Irie et al., 2002). Bfr1p is a protein of unknown
function that was found in a screen for resistance against
brefeldin A (Jackson and Kepes, 1994). Brefeldin A is a
noncompetitive inhibitor of ARF-GEFs (Peyroche et al.,
1999). Bfr1p is required for the association of Scp160p with
polysomes but not with Pab1p (Lang et al., 2001). In addi-
tion, we found that bfr1 and arf1 are synthetically lethal at
37°C (Figure 7B). Furthermore, Bfr1p coimmunoprecipitates
with Arf1p (Figure 7C). Therefore, at least a part of Arf1p
function might be connected to Scp160p and Bfr1p, and it
seemed likely that bfr1 also might be deficient in correct
mRNA localization. Indeed, bfr1 showed the same pheno-
type as scp160, which was stronger than the one observed
for arf1 and pab1 sbp8 (Figure 7A). This is consistent
with the probable involvement of Scp160p and Bfr1p in the
general translation machinery. In the absence of Arf1p, some
mRNA could still get to the ER and interact there with
Scp160p or Bfr1p. However, upon deletion of BFR1 or
SCP160 the translation and thus restriction of mRNA at the
ER could be more severely affected.
Characterization of the Cytoskeleton in the arf1 Mutants
So far, we presented evidence that Arf1p is involved in mRNA
transport and that the existence of an Arf1p-Pab1p-ASH1 ribo-
nucleotide particle seemed to be independent of the SHE ma-
chinery. ASH1 mRNA was mislocalized in ARF mutants as
determined by two different methods (Figures 5 and 6C). How-
ever, it is known that mutations in ARF also can affect the actin
cytoskeleton and also might have some effect on microtubules.
To rule out any general defects in cytoskeletal organization or
polarity, we examined the microtubules and actin cytoskeleton
in the NYY strains at the permissive and restrictive tempera-
ture. All strains showed wild-type microtubules at both tem-
Figure 6. Arf1p and Pab1p are required for ASH1 mRNA localization to the bud tip. (A) Overview of scored phenotypes. (B) List of mutants
used in the analysis in C. (C) The defect in mRNA localization is allele specific. Different mutants in ARF1 were grown to early log phase at
23°C and then shifted for 1 h to 37°C. ASH1 mRNA in the cells was visualized by FISH. At least 100 cells/strain were scored. (D) ASH1
mRNA levels are not sensitive to shift to the restrictive temperature. Different mutants in ARF1 were grown to early log phase at 23°C and
then shifted for 1 h to 37°C; the deletion mutants in ARF1 and PAB1 SPB8 as well as a wild-type strain were grown at 30°C. Total RNA was
extracted from the different strains and analyzed by Northern blot. The blot was incubated with probes for ASH1 mRNA and ADH1 mRNA.
On temperature shift, no significant changes in mRNA levels were observed. (E) Ash1p levels are not altered in different mutants. The strains
were transformed with a CEN plasmid encoding C-terminally myc9-tagged Ash1p and grown as described in D. Soluble extracts were
prepared and analyzed by immunoblot for the presence of Ash1p-myc and Arf1p. The translation of ASH1 mRNA seemed to be unaffected
by shift to restrictive temperature. The Arf-signal in the arf1 mutant corresponds to Arf2p, which is up-regulated in arf1 strains. Arf2p is
10 times less than abundant than Arf1p in wild-type strains.
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peratures as judged by indirect immunofluorescence (our un-
published data). In addition, none of the strains was sensitive
toward benomyl, a microtubule depolymerizing drug. Next,
we examined the actin localization by staining with rhoda-
mine-phalloidin. NYY0-1, NYY11-1, and NYY17-1 did show
correctly polarized actin cables and patches at the permissive
and the restrictive temperature (Figure 8A). In contrast,
whereas NYY18-1 behaved like wild type at 23°C, after the shift
to the nonpermissive temperature the actin cables were miss-
ing and the actin patches were distributed randomly through-
out the cell. Thus, the mRNA localization defect in NYY18-1
might be explained by the aberrant actin cytoskeleton. How-
ever, the polarity of the cell was not entirely lost, because bud
site selection and budding still seemed to be normal as in the
other strains tested (our unpublished data). The second arf1
mutant with an ASH1 mRNA localization defect, NYY11-1,
behaved like wild type. Thus, the mRNA distribution pheno-
type in at least NYY11-1 is not caused by general defects in
polarity and cytoskeletal organization.
She1p/Myo4p Localizes Correctly to the Bud Tip in arf1
Mutants
The actin cytoskeleton was visibly disturbed only in
NYY18-1 at the restrictive temperature. Nonetheless, more
Figure 7. Pab1p binding proteins display
abnormal ASH1 mRNA localization. Cells
were grown to early log phase at 30°C, and
FISH for ASH1 mRNA was performed.
BY4741 is the corresponding wild-type for
the strains in A. At least 100 cells/strain
were scored. (B) ARF1 and BFR1 interact
genetically. Single and double mutants in
ARF1 and BFR1 were grown at 30°C. Serial
dilutions were dropped on plates and incu-
bated at the indicated temperatures for 2 d.
(C) Bfr1p interacts with Arf1p. An immuno-
precipitation from yeast lysate was per-
formed with affinity-purified antibodies
against Arf1p or control IgGs. Bfr1p was
coprecipitated with Arf1p.
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subtle defects might conceivably prevent the SHE machin-
ery from reaching the bud tip in the arf mutants. To test this
possibility, we determined the localization of the motor
protein She1p/Myo4p in the arf1 point mutants. The local-
ization of She1p/Myo4p in the bud tip depends on the
presence of She2p and She3p (Kruse et al., 2002). Thus, by
checking She1p/Myo4p, we can examine the functionality of
the entire SHE machinery. MYO4 was chromosomally ap-
pended by 2  GFP in the different NYY strains as described
by Kruse et al. (2002). At the permissive temperature as well
as after a shift to the restrictive temperature for at least 1 h,
Myo4p-GFP localized correctly to the bud tip in the arf1
point mutants irrespective to their defect in ASH1 mRNA
localization (Figure 8B). Most importantly, Myo4p-GFP was
localized correctly at the bud tip in NYY11-1 and NYY18-1
(Figure 8B). Our data indicate that the SHE machinery is
functional in the arf1 mutants and that Arf1p is most likely
involved in retaining ASH1 mRNA in the bud tip after the
Figure 8. Localization of She1p/Myo4p
and actin in arf1 point mutants. (A) The
actin cytoskeleton is only disturbed in
NYY18-1 at the restrictive temperature. Dif-
ferent mutants in ARF1 were grown to early
log phase at 23°C and then shifted for 1 h to
37°C. Cells were fixed and the actin cy-
toskeleton was stained with rhoda-
mine-phalloidin. (B) She1p/Myo4p local-
izes to the bud tip in arf1mutants. MYO4
was chromosomally appended with 2 
GFP. Different mutants in ARF1 were grown
to early log phase at 23°C and then shifted
for 1 h to 37°C. Cells were examined di-
rectly. For the restrictive temperature, a
heated stage was mounted onto the micro-
scope to keep the cells at 37°C during the
observation.
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SHE proteins fulfilled their duty. These results demonstrate
that the involvement of Arf1p in mRNA localization is in-
dependent of the SHE machinery. This is in agreement with
our findings that the coatomer–Arf1p–Pab1p complex con-
tains also symmetrically localized mRNAs that are not a
substrate for the SHE machinery and that the deletion of
members of the SHE machinery did not sever the ASH1
mRNA interaction with Pab1p and Arf1p.
Components of the Early Secretory Pathway Are Required
for ASH1 mRNA Localization
We found that mRNA is associated with COPI-coated vesi-
cles that are destined to the ER. Therefore, we wondered
whether vesicular traffic, especially through COPI transport
carriers, might play a role in mRNA localization. To this end,
we performed FISH with temperature-sensitive mutants in
components of the early secretory pathway. Surprisingly,
not only sec21-1, a mutant in the -subunit of coatomer was
defective but also sec23-1 and sar1-D32G (Figure 9). Sar1p is
the counterpart of Arf1p in the generation of COPII vesicles,
and Sec23p is the GTPase activating protein for Sar1p (Bar-
lowe, 2000). Furthermore, the N-ethylmaleimide-sensitive
factor Sec18p, which is involved in homotypic and hetero-
typic membrane fusion (Novick et al., 1981; Graham and
Emr, 1991), also seemed to be required for the anchoring of
ASH1 mRNA because in 80% of the cells the FISH signal
was mostly distributed all over the cell and could not be
found concentrated in the bud tip. In contrast, two other
mutants in the -subunit (sec27) and -subunit (sec28) of
coatomer behaved like wild type, indicating that the mRNA
localization is a specific event involving coatomer. The phe-
notype that we detected was not due to a general secretion
defect, because mutants in two Arf1p interacting proteins,
Gga2p and Gcs1p, were not defective in ASH1 mRNA lo-
calization. Our results indicate that restricting ASH1 mRNA
to the bud tip requires functional ER-Golgi transport.
The Actin Cytoskeleton Is Not Generally Disturbed in ER-
Golgi Transport Mutants
We repeated the actin-phalloidin staining with the temper-
ature-sensitive secretion mutants that were defective in
ASH1 mRNA localization (Figure 10). The mutant strains
sec18-1, sec21-1, and sar1-D32G displayed a correctly polar-
ized actin cytoskeleton at the permissive and at the restric-
tive temperature. In contrast, sec23-1 cells had a disorga-
nized actin cytoskeleton after 1-h shift to the restrictive
temperature. Thus, the defect in mRNA localization in these
mutants (except for sec23-1) is not due to a lack of actin
organization in the cell.
Together, our results indicate a novel and unexpected role
for components of the early secretory pathway in short-
range mRNA localization most likely through interaction
with Pab1p. This process is independent of the SHE machin-
ery. We have only investigated the localization of the asym-
metrically localized mRNA ASH1. However, these results
also might reflect a mechanism by which symmetrically
localized mRNA is concentrated at the ER.
DISCUSSION
We have used a differential affinity chromatography ap-
proach to identify new interactors of the small GTPase
Arf1p. This approach is valid because known regulators
were reidentified. We have identified Pab1p as a new inter-
actor of the small GTPase Arf1p. Pab1p interacts predomi-
nantly with the GTP-bound form of Arf1p. In a high-
throughput protein complex analysis in yeast, Pab1p was
found to be one of the major contaminants (Gavin et al.,
2002), indicating that Pab1p might interact nonspecifically
with many other proteins. Therefore, we confirmed the spec-
ificity of interaction by two-hybrid analysis and genetic in-
teraction as well as by mutual coimmunoprecipitation. Fur-
thermore, the interaction between Pab1p and Arf1p is
dependent on the presence of mRNA in the complex. More-
over, we found that Pab1p is associated peripherally with
COPI vesicles generated from enriched Golgi membranes.
Together, these results argue strongly that the Arf1p–Pab1p
complex is specific. If and how Pab1p is incorporated into
the vesicle coat remains elusive at present. Pab1p might not
become an intrinsic part of the coat but might be peripher-
ally associated with the vesicles through interactions with
Arf1p and coatomer. COPI vesicles still form upon RNase
Figure 9. A functional early secretory
pathway is necessary for ASH1 mRNA lo-
calization. Strains were grown to early log
phase at 30°C or 23°C for ts-strains. In case
of the ts-strains, one-half of the cultures
were shifted to 37°C for 1 h. RSY248 corre-
sponds to the wild-type strain for the ts-
mutants and is isogenic to sec18-1. BY4741 is
the corresponding wild type for the deletion
strains. At least 100 cells were scored per
strain and condition.
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treatment, which prohibits the Pab1p interaction with the
coat.
We tested Arf1p immunoprecipitates for the presence of a
number of different mRNAs that varied in their abundance
and in their subcellular localization, by RT-PCR. After the
immunoprecipitation, essentially all mRNAs were ampli-
fied. Thus, no specialized 3 end processing complexes were
associated with COPI vesicles. To further investigate the role
of Arf1p, Pab1p, and the COPI coat in mRNA transport, we
concentrated our efforts in studying the asymmetrically dis-
tributed ASH1 mRNA. In wild-type cells, ASH1 mRNA is
asymmetrically localized to the bud tip of a growing yeast
Figure 10. The actin cytoskeleton is not disturbed as a result of a defect in secretion. Secretion mutants that displayed an ASH1 mRNA
localization defect were examined for a functional actin cytoskeleton. The strains were grown to early log-phase at 23°C and then shifted for
1 h to 37°C. Cells were fixed and actin was stained with rhodamine-phalloidin.
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cell. However, when we investigated the role of mutants in
ARF1 and PAB1 in asymmetric mRNA distribution, we
found that they mislocalize ASH1 mRNA. Furthermore, by
using enriched COPI vesicles from the Golgi budding assay,
we could detect ASH1 mRNA by RT-PCR.
The fact that the ASH1 mRNA mislocalization phenotype
in arf1 mutants was allele specific indicates that not the
whole repertoire of ARF-dependent traffic is needed for
mRNA localization. Moreover, this finding provides strong
evidence that the ASH1 mRNA localization defect is not
brought about by a secondary effect. This idea is corrobo-
rated by the data showing that some coatomer mutants did
show a defect, whereas others did not. Furthermore, the
extent of ASH1 mRNA mislocalization was variable in the
different mutants of the early secretory pathway. However,
other mutants of the early secretory pathway localized
ASH1 mRNA correctly to the bud tip. Thus, the asymmetric
mRNA distribution phenotype cannot be attributed to a
general secretion defect. In addition to mutants in the early
secretory pathway, we tested also mutants in late-acting
components. They either had no effects (gga2) or the ASH1
mRNA mislocalization phenotype could be related to a de-
fect in the actin cytoskeleton (sec1-1 and sec6-4; Trautwein
and Spang, unpublished data). Moreover, the ASH1 mRNA
localization defect was not due to defects in the actin cy-
toskeleton, the microtubules’ organization, or cell polarity.
Finally, we ruled out the possibility that ASH1 mRNA sta-
bility or translation efficiency was compromised in arf1 mu-
tants. Ribosome biosynthesis and translation efficiency are
affected in secretion mutants (Mizuta and Warner, 1994;
Deloche et al., 2004). However, we did not observe this effect
in arf1 and pab1spb8 mutants, which is most likely due to
the use of different mutants and different strain back-
grounds: the pool of mutants tested in the various studies is
nonoverlapping. Yet, we cannot exclude that there are subtle
effects on translation or on the cytoskeleton that we were not
able to detect by our methods of choice. Nevertheless, we
think it unlikely that the mRNA localization defect results
entirely from such secondary effects.
Transport of asymmetrically distributed mRNA into the
bud tip was shown to be dependent upon the SHE proteins:
She1p/Myo4p is an unconventional myosin that transports
She2p, an RNA binding protein. The interaction between
these two proteins is mediated by She3p. The role of She4p
and She5p/Bni1p in mRNA localization is less well under-
stood, but they seem to be involved in stabilization and
polarization of the actin cytoskeleton. They are thought to
play a role in anchoring mRNA by a thus far unknown
mechanism (Beach and Bloom, 2001). However, Bloom and
Beach (1999) speculated that once mRNA reaches the vicin-
ity of its final destination, cytoplasmic flow or passive dif-
fusion may enable mRNA accumulation at that site (the bud
tip in yeast). Thus, a mechanism for restricting ASH1 mRNA
in the bud is required, which might be independent of the
SHE machinery. It further indicates the transport by the SHE
machinery is a prerequisite but not sufficient for anchoring
ASH1 mRNA at the bud tip. This is in perfect agreement
with our finding that the aberrant ASH1 mRNA localization
observed could not be correlated with defects in the SHE
machinery, because Myo4p-GFP was restricted to the bud
tip in arf1 mutants. Furthermore, deletion of SHE1/MYO4 or
SHE3 did not disrupt the Arf1p-Pab1p ribonucleotide parti-
cle. Therefore, the defects in ASH1 mRNA localization in the
early secretion mutants are independent and most likely
downstream of the SHE machinery. Our data are suggestive
of COPI vesicles acting as short-range mRNA transport and
localization vehicles: The asymmetric distribution of the
ASH1 mRNA is brought about by the SHE machinery and
does not depend on Arf1p and COPI vesicles; they may act
only to restrict the mRNA in the bud tip when it is not
efficiently anchored. The long-range mRNA transport is de-
pendent on the SHE machinery, whereas the short-range
localization might be reliant on COPI vesicles.
We concentrated our efforts on the study of the asym-
metrically distributed ASH1 mRNA, because the pathway of
ASH1 mRNA localization is well known and more amenable
for experiments than symmetrically distributed mRNA.
However, because the defects in mRNA localization are
independent of the SHE machinery, our observations also
could apply to the symmetrically distributed mRNAs. What
might be the role then of the early secretory pathway in
mRNA localization? We would like to suggest a model in
which the mRNA is transported to the ER via the COPI
machinery. This mRNA COPI interaction could take place at
the Golgi. Pab1p was detected on purified Golgi membranes
that we used to generate COPI vesicles in vitro. These ves-
icles contained proteins (e.g., the ER-Golgi v-SNARE Bos1p)
that cycle between the Golgi and the ER. Thus, we believe
that these COPI vesicles are destined to the ER. Alterna-
tively, the COPI vesicles might be directly loaded on route.
This would lead to a fast and efficient way to bring mRNA
to the ER. If the mRNA cannot be anchored at the ER and
diffuses away, the COPI vesicles destined to the ER might be
an efficient transport system for relocation of the mRNA.
Thus, COPI vesicles could act as molecular sieve to bring
Pab1p containing ribonucleotide particles to the ER. Yet, one
other possible explanation for the transport of mRNA on
COPI vesicles might be the clearance of the ribosome-free
Golgi region from mRNA. Although this might be a likely
scenario for mammalian cells, the Golgi in S. cerevisiae is
scattered throughout the cell, and the single different cister-
nae are surrounded by ribosomes in the cytoplasm. There is
no ribosome-free Golgi region in S. cerevisiae. Still, we cannot
exclude the possibility that there might be an ancient mech-
anism for mRNA clearance. Alternatively, symmetrically
and asymmetrically mRNA transport to the ER might result
in an enhancement of membrane-bound ribosome turnover
at the ER. At least in mammalian cells, it has been shown
that membrane-bound ribosomes do not distinguish be-
tween mRNA substrates and therefore can initiate the trans-
lation of any protein, regardless of whether it is cytosolic or
destined for translocation/secretion (Potter and Nicchitta,
2000). However, when membrane-bound ribosomes were
provided with mRNAs encoding model cytosolic proteins,
subsequent translation yielded the release of the ribosome-
nascent chain complex from the ER to the cytosol (Potter and
Nicchitta, 2000; Potter et al., 2001). Furthermore, mRNAs
encoding cytosolic proteins are well represented in the ER
membrane-bound polysome fraction (Diehn et al., 2000; Le-
rner et al., 2003). Nicchitta (2002) proposed a model suggest-
ing that the exchange of ribosomes on the ER membrane is
dependent on and driven by the translation of cytosolic
proteins by membrane-bound ribosomes. Our data are in
agreement with this hypothesis because COPI vesicles could
act as carriers for mRNAs to the ER to allow for the ribosome
exchange.
The mutant in the COPII component Sar1p could display
such a strong defect for two reasons, which might lead to an
additive effect: Because COPII vesicles are no longer formed
in these mutants, the lipid and protein composition of the ER
membrane is changed. As a result, the mRNA complex
might “adhere” less efficiently at the ER membrane. The
mRNA complex diffuses away and cannot be brought back
because blocking anterograde COPII transport from the ER
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to the Golgi immediately abrogates retrograde COPI trans-
port from the Golgi to the ER. Hence, one would observe a
stronger phenotype than in the retrograde transport mu-
tants. Although we cannot exclude a direct involvement of
COPII components in mRNA localization, Pab1p did not
interact with Sar1p or Sec23p. Therefore, we favor an indi-
rect role of the COPII components in mRNA transport.
Together, our results provide the first evidence for a link
between COPI vesicles and mRNA. Our data are suggestive
of a role of Pab1p and COPI vesicles in concentrating mRNA
at the ER. However, given the multiple roles of Arf1p in the
cell and the interdependence of vesicular transport and me-
tabolism, other interpretations for the in vivo role of RNA-
loaded vesicles also are conceivable.
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